HORIBA Medical and LabThruPut Sign a Distribution Agreement Covering the US & Canada for the LabThruPut Middleware Platform
HORIBA Medical and Labthroughput LLC (LabThruPut) announced that they have entered into an agreement for the US & Canadian distribution of the Laboratory Decision Support Software by LabThruPut, which allows Auto-Verification and sample follow-up across laboratory disciplines and enables connectivity to multiple sites and multiple Laboratory Information Systems of virtually an unlimited number of instruments.
“The addition of LabThruPut to the full suite of HORIBA Medical’s product line makes it possible for a wide range of clinical laboratories to realize efficiencies resulting from a powerful yet very user friendly decision support software product that includes productivity management tools. LabThruPut is pleased to serve as HORIBA Medical’s Middleware provider in this effort” said Victor Schabes, Director of Business Development. “HORIBA Medical equips more than 30,000 laboratories throughout the World, distributed in 110 countries in 5 continents. Not only we are proud to work with a partner who holds world records in its industry, but we are confident that this agreement has huge potential.”
The LabThruPut Middleware distributed by HORIBA Medical will integrate all Auto-Validation and sample follow-up features across laboratory disciplines, with the capability of access from a single work station. These features include patient-result and QC review rules and rule sets that are very easy to enable/disable/edit/clone, as well as full audit-trailing of results.
“LabThruPut is an important enhancement of our laboratory instrumentation product offerings” said Riad Abuelafiya, VP & General Manager, HORIBA Medical. “The addition of LabThruPut Middleware to our products makes it possible for HORIBA Medical to provide a complete solution to our wide base of customers across laboratory disciplines and also to facilitate the integrated management of laboratory data within the global IVD Laboratory”.
About Horiba Medical:
HORIBA Medical Segment designs, develops and distributes worldwide, in vitro diagnostic systems mainly destined for biological analysis in medical laboratories. These automated analyzers meet the needs of various users including patients, doctors, private laboratories, clinics and university hospitals. HORIBA expertise in in vitro diagnostics is one of the most respected in hematology worldwide and contribute today to the health of tomorrow.
About LabThruPut:
LabThruPut provides instrument-to-host connectivity for in-vitro diagnostic analyzers (IVD) that produce numerical, non-numeric, graphical, and image-based results; and analysis of those results. The connectivity includes creation of and implementation of unidirectional and bi-directional data exchange interfaces to both instruments and host computer systems. The results analysis includes the ability for users to create and activate results review criteria that include review outcome-based follow-up procedures. Our platform includes graphical user interfaces that enable users to process follow-up procedure instructions. These functions are integrated with various productivity improvement tools enabling users to optimize results throughput and improve laboratory workflow efficiency.
